Literature Citations
1. Highly Surface Active Anisotropic Silver Nanoparticles as Antimicrobial Agent against Human Pathogens, Mycobacterium smegmatis and Candida albicans. Agnihotri, A.S., Z. Fatima, S. Hameed, and M. Nidhin. ChemistrySelect, 2021. 6(22): p. 5466-5473. ISI[000663296300013].
[WOS]. TB_07_2021.
2. Benzo[a]phenazine Derivatives: Promising Scaffolds to Combat Resistant Mycobacterium tuberculosis. Halicki, P.C.B., E.N.J. da Silva, G.A.M. Jardim, R.G. Almeida, J.R.M. Vicenti, B.L. Gonçalves, P.E.A. da Silva, and D.F. Ramos. Chemical Biology & Drug Design, 2021. 98(3): p. 352-362. PMID[33932096].
[PubMed]. TB_07_2021.
3. Antituberculosis Activities of Lapachol and Β-Lapachone in Combination with Other Drugs in Acidic pH. Ieque, A.L., H.C. Carvalho, V.P. Baldin, N.C.S. Santos, G.F. Costacurta, E.G. Sampiron, C.M.M. Fernandez de Andrade, V.L.D. Siqueira, K.R. Caleffi Ferracioli, R.F. Cardoso, D.A.G. Cortez, E.L. Silva, and R.B.L. Scodro. Microbial Drug Resistance, 2021. 27(7): p. 924-932. PMID[33275860].
[PubMed]. TB_07_2021.
4. In Vitro Anti Tubercular Activity and Physicochemical Standardization of Selected Medicinal Plant Extracts. Martolia, J., H. Soni, and F. Tandel. Indian Journal of Pharmaceutical Sciences, 2021. 83(2): p. 230-237. ISI[000663826300006].
[WOS]. TB_07_2021.
5. The Anti-tubercular Activity of Noni fruitsto Inhibition Growth of Multi Drug Resistant-tuberculosis Bacteria. Mauliku, N.E. and E. Knowledge. 4th International Virtual Conference on Nursing, 2021: p. 979-990. ISI[000662211700092].
[WOS]. TB_07_2021.
6. Synthesis of Alkynylated 1,2,4-Oxadiazole/1,2,3-1H-Triazole glycoconjugates: Discovering New Compounds for Use in Chemotherapy against Lung Carcinoma and Mycobacterium tuberculosis. Melo de Oliveira, V.N., C. Flávia do Amaral Moura, A.D.S. Peixoto, V.P. Gonçalves Ferreira, H.M. Araújo, L.M. Lapa Montenegro Pimentel, C. Pessoa, R. Nicolete, J. Versiani Dos Anjos, P.P. Sharma, B. Rathi, L.J. Pena, P. Rollin, A. Tatibouët, and R. Nascimento de Oliveira. European Journal of Medicinal Chemistry, 2021. 220: 113472. PMID[33940463].
[PubMed]. TB_07_2021.
7. Design, Synthesis and Antitubercular Activity of 2-(Benzylthio)-1H-benzo[D]imidazoles. Rambo, R.S., E.C. Waldow, B.L. Abaddi, M.D. Silveira, A.S. Dadda, N. Sperotto, C.V. Bizarro, L.A. Basso, and P. Machado. Journal of the Brazilian Chemical Society, 2021. 32(7): p. 1413-1423. ISI[000655661000010].
[WOS]. TB_07_2021.
8. A Novel Dipeptide Coupled with Pyrazine-oxadiazole Derivative as a Potential Antitubercular Agent: Synthesis, Radioiodination and Bioevaluation. Shamsel-Din, H.A. and M.A. Gizawy. Applied Radiation and Isotopes, 2021. 173: 109719. PMID[33915408].
[PubMed]. TB_07_2021.
9. Excellent Synergistic Activity of a Designed Membrane Acting Pyridinium Containing Antimicrobial Cationic N-Acylethanolamine with Isoniazid against Mycobacterium. Subramaniyan, S.B., M. Sengan, R. Subburethinam, and A. Veerappan. New Journal of Chemistry. ISI[000663053500001].
[WOS]. TB_07_2021.
10. Anti-tubercular Activity and Molecular Docking Studies of Indolizine Derivatives Targeting Mycobacterial InhA Enzyme. Venugopala, K.N., S. Chandrashekharappa, P.K. Deb, C. Tratrat, M. Pillay, D. Chopra, N.A. Al-Shar'i, W. Hourani, L.A. Dahabiyeh, P. Borah, R.D. Nagdeve, S.K. Nayak, B. Padmashali, M.A. Morsy, B.E. Aldhubiab, M. Attimarad, A.B. Nair, N. Sreeharsha, M. Haroun, S. Shashikanth, V. Mohanlall, and R. Mailavaram. Journal of Enzyme Inhibition and Medicinal Chemistry, 2021. 36(1): p. 1472-1487. PMID[34210233]. PMCID[PMC8259857].
[PubMed]. TB_07_2021.
11. Activity of Oritavancin and Its Synergy with Other Antibiotics against Mycobacterium abscessus Infection in Vitro and in Vivo. Wang, G., J. Tang, J. Feng, W. Dong, X. Huo, H. Lu, C. Wang, W. Lu, X. Wang, H. Chen, and C. Tan. International Journal of Molecular Sciences, 2021. 22(12). PMID[34198513]. PMCID[PMC8231898].
[PubMed]. TB_07_2021.
Patent Citations
This month, no relevant Mycobacterium spp. patents were identified.